Jubilant Pharmova Ltd - 530019 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificate / Duplicate Share Certificate20-10-2023
20-10-2023
Jubilant Pharmova Ltd - 530019 - Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2023.
Jubilant Pharmova Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2023 ,inter alia, to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2023.19-10-2023
Jubilant Pharmova Ltd - 530019 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Regulation 74(5) of SEBI (DP ) Regulations, 201813-10-2023
Jubilant Pharmova Ltd - 530019 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issuance of Letter of Confirmation28-09-2023
Jubilant Pharmova Ltd - 530019 - Closure of Trading Window
Intimation regarding closure of trading window22-09-2023
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
Appointment of M/s. Walker Chandiok & Co LLP as Statutory Auditors of the Company31-08-2023
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Change in Management
Re-appointment of Mr. Arun Seth as Independent Director of the Company31-08-2023
Jubilant Pharmova Ltd - 530019 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
AGM Proceedings and Scrutinizer''s Report31-08-2023
Jubilant Pharmova Ltd - 530019 - Shareholder Meeting / Postal Ballot-Outcome of AGM
AGM Proceedings and Voting Results31-08-2023
Hot Stocks | Here is why you should bet on Bank of Maharashtra, Jubilant Pharmova, Paytm for short term
A significant breakthrough above the 19,500 mark could potentially trigger a rally towards higher levels.24-08-2023